Stockreport

Kineta to Participate in Upcoming Investor Conferences

Kineta, Inc.  (KA) 
PDF SEATTLE, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in onc [Read more]